Inventor · disambiguated record
Robert J. Miller
Also filed as: MILLER ROBERT · MILLER ROBERT J · MILLER ROBERT JAMES
36 granted patents·18 pending applications·935 citations·filing 1992–2024
98Inventor score
Top patents by PatentIndex Score
54 records- 0198US6521223B1Single phase gels for the prevention of adhesionsGENZYME CORP·Filed 2000·Granted Feb 18, 2003·206 cites·15 claims
- 0296US11130816B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2019·Granted Sep 28, 2021·6 cites·20 claims
- 0395US12110338B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2021·Granted Oct 8, 2024·2 cites·29 claims
- 0495US5760200AWater insoluble derivatives of polyanionic polysaccharidesGENZYME CORP·Filed 1995·Granted Jun 2, 1998·124 cites·21 claims
- 0594US9580511B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2014·Granted Feb 28, 2017·17 cites·47 claims
- 0693US10214589B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2017·Granted Feb 26, 2019·9 cites·18 claims
- 0792US11279725B2Oligosaccharide-protein conjugatesGENZYME CORP·Filed 2019·Granted Mar 22, 2022·6 cites·19 claims
- 0890US6749865B2Modification of biopolymers for improved drug deliveryGENZYME CORP·Filed 2001·Granted Jun 15, 2004·26 cites·16 claims
- 0990US2025066497A1Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2024·Application pending·0 cites
- 1089US6030958AWater insoluble derivatives of hyaluronic acidGENZYME CORP·Filed 1997·Granted Feb 29, 2000·73 cites·21 claims
- 1188US6610669B1Water insoluble derivatives of polyanionic polysaccharidesGENZYME CORP·Filed 1999·Granted Aug 26, 2003·53 cites·23 claims
- 1287US12162994B2Biocompatible hydrogel capsules and process for preparing sameSIGILON THERAPEUTICS INC·Filed 2019·Granted Dec 10, 2024·2 cites·14 claims
- 1387US10464962B2Oligosaccharide-protein conjugatesGENZYME CORP·Filed 2016·Granted Nov 5, 2019·5 cites·6 claims
- 1487US7022343B2Controlled release of anti-arrhythmic agentsGENZYME CORP·Filed 2001·Granted Apr 4, 2006·40 cites·7 claims
- 1587US6383344B1Molecular weight reduction of polymer using irradiation treatmentGENZYME CORP·Filed 2000·Granted May 7, 2002·40 cites·8 claims
- 1686US8835614B2Oligosaccharide-protein conjugatesAVILA LUIS Z·Filed 2009·Granted Sep 16, 2014·10 cites·15 claims
- 1786US5527893AWater insoluble derivatives of polyanionic polysaccharidesGENZYME CORP·Filed 1992·Granted Jun 18, 1996·90 cites·8 claims
- 1884US9493498B2Oligosaccharide-protein conjugatesGENZYME CORP·Filed 2014·Granted Nov 15, 2016·6 cites·14 claims
- 1983US7456220B2Immunodulatory compositions and methods of use thereofGENZYME CORP·Filed 2005·Granted Nov 25, 2008·2 cites·1 claims
- 2083US2025206893A1Biocompatible hydrogel capsules and process for preparing sameSIGILON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2182US9611357B2Chemically modified dendrimersGENZYME CORP·Filed 2015·Granted Apr 4, 2017·1 cites·19 claims
- 2282US7189413B2Drug delivery of proteins from polymeric blendsGENZYME CORP·Filed 2002·Granted Mar 13, 2007·11 cites·23 claims
- 2380US12306081B2Apparatuses and methods for formation of particlesSIGILON THERAPEUTICS INC·Filed 2020·Granted May 20, 2025·1 cites·29 claims
- 2480US11945786B2Compounds, devices, and uses thereofSIGILON THERAPEUTICS INC·Filed 2017·Granted Apr 2, 2024·2 cites·11 claims
- 2580US6943154B2Water insoluble derivatives of polyanionic polysaccharidesGENZYME CORP·Filed 2001·Granted Sep 13, 2005·29 cites·16 claims
- 2679US12252504B2Oligosaccharide-protein conjugatesGENZYME CORP·Filed 2022·Granted Mar 18, 2025·0 cites·5 claims
- 2778US12161760B2Implantable particles and related methodsSIGILON THERAPEUTICS INC·Filed 2019·Granted Dec 10, 2024·2 cites·27 claims
- 2873US6235726B1Water insoluble derivatives of polyanionic polysaccharidesGENZYME CORP·Filed 1999·Granted May 22, 2001·89 cites·24 claims
- 2972US6174999B1Water insoluble derivatives of polyanionic polysaccharidesGENZYME CORP·Filed 1992·Granted Jan 16, 2001·66 cites·24 claims
- 3072US2025235409A1Implantable particles and related methodsSIGILON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3171US8658148B2Chemically modified dendrimersAVILA LUIS Z·Filed 2008·Granted Feb 25, 2014·1 cites·26 claims
- 3269US2017209482A1Chemically Modified DendrimersGENZYME CORP·Filed 2017·Application pending·0 cites
- 3366US9326994B2Amine functional polyamidesGENZYME CORP·Filed 2014·Granted May 3, 2016·1 cites·22 claims
- 3466US9283247B2Chemically modified dendrimersGENZYME CORP·Filed 2014·Granted Mar 15, 2016·0 cites·20 claims
- 3562US2009192079A1Prolonged delivery of heparin-binding growth factors from heparin-derivatized collagenGENZYME CORP·Filed 2008·Application pending·0 cites
- 3661US7387836B2Aziridine compounds and their use in medical devicesGENZYME CORP·Filed 2003·Granted Jun 17, 2008·9 cites·52 claims
- 3760US7186725B2Anti-inflammatory compositions and methodsGENZYME CORP·Filed 2003·Granted Mar 6, 2007·1 cites·10 claims
- 3854US2025000788A1Biocompatible devices for cell-based therapies and related methodsSIGILON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3949US10113032B2Amine functional polyamidesGENZYME CORP·Filed 2016·Granted Oct 30, 2018·0 cites·4 claims
- 4048US2013251683A1Prolonged delivery of heparin-binding growth factors from heparin-derivatized collagenGENZYME CORP·Filed 2013·Application pending·0 cites
- 4148US2016024233A1Sequestrants of advanced glycation end product (age) precursorsGENZYME CORP·Filed 2014·Application pending·0 cites
- 4247US2023123802A1Compositions, devices, and methods for factor vii therapySIGILON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4346US7417021B2Biologically active conjugate of a biopolymer and therapeutic agentGENZYME CORP·Filed 2004·Granted Aug 26, 2008·5 cites·23 claims
- 4446US2005281866A1Adherent polymeric compositionsGENZYME CORP·Filed 2005·Application pending·0 cites
- 4546US2021145889A1Methods, compositions, and implantable elements comprising stem cellsSIGILON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4645US2006204537A1Silicone blends and composites for drug deliveryGENZYME CORP·Filed 2003·Application pending·0 cites
- 4745US2018265613A1Sequestrants of advanced glycation end product (age) precursorsGENZYME CORP·Filed 2017·Application pending·0 cites
- 4844US2022000789A1Implantable devices for cell therapy and related methodsSIGILON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4943US2002156146A1Molecular weight reduction of polymer using irradiation treatmentGENZYME CORP·Filed 2002·Application pending·0 cites
- 5043US2022267794A1Compositions, devices, and methods for treating fabry diseaseSIGILON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Robert J. Miller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →